Novo Nordisk partners with Apollo Clinics to launch comprehensive obesity clinic program in India

New Delhi: Novo Nordisk, the global leader in chronic disease care, has announced a strategic collaboration with Apollo Clinics to launch a comprehensive Obesity Management Program across various cities in India.

This initiative aims to address the growing burden of overweight and obesity through a structured, multi-tiered care model focused on empowering individuals living with overweight or obesity and developing specialised programs for obesity care.

With this collaboration, Apollo Clinics and Novo Nordisk will integrate a comprehensive obesity care framework across select centres. The program includes robust HCP training via the WeLearn Obesity Education Series, in-clinic diagnostic and patient engagement tools, and capability-building modules for dieticians, physiotherapists and behavioural specialists. As part of this partnership, Apollo Clinics will bring its expertise as a pioneer in running condition management programs and will now provide support like infrastructure, clinical pathways and digital patient support tools to deliver comprehensive evidence-based obesity care. This initiative will also feature dedicated patient awareness campaigns, including educational videos, booklets, and body composition analysis. A QR-enabled platform will provide access to BMI and waist-to-height ratio calculators, connecting users to appropriate care pathways.

Dr Maya Sharma, Vice President – Clinical, Medical & Regulatory, Novo Nordisk India, said, “The prevalence of obesity continues to rise in India, yet clinical recognition remains inadequate. Novo Nordisk aims to transform how obesity is understood, diagnosed and managed at the primary level across the nation. The mission of this partnership with Apollo Clinics is to equip healthcare professionals with robust clinical education, patient-centric tools and infrastructure support they need to deliver personalised and evidence-based healthcare interventions that go beyond symptom management. Together, we hope to drive lasting behavioural and health outcomes, ultimately improving quality of life for millions of Indians living with overweight or obesity.”

Sriram Iyer, CEO – Apollo Health & Lifestyle Limited said, “This partnership reinforces our long-standing commitment to address the complex challenge of Obesity and weight related conditions in India and will help to address chronic lifestyle diseases with innovation and clinical excellence. Apollo Clinics with its wide-reaching network along with Novo Nordisk’s global expertise in obesity care, plans to deliver more structured, evidence-based support to patients living with obesity across India. Together, we look forward to creating a care model that is accessible, sustainable and truly patient-centric.”

Obesity in India affects more than 250 million adults, and is linked to over 230 health complications, including cardiovascular disease, diabetes, cancer and obstructive sleep apnoea. The proportion of individuals with overweight and obesity in India shows significant variation by state, ranging from 8% to 50%, and spans all demographics, including men and women across both rural and urban populations. The economic burden of obesity-related diseases in India is projected to reach ₹36,000 crores by 2030.